Furthermore, a recent study using only clinical samples showed that higher levels of MYBL2 were associated with poor prognosis, poor differentiation, and lymph node metastasis (44), suggesting that MYBL2 may have an oncogenic function in GC. This evidence concerns the gene MYBL2 and metastatic malignant neoplasm in the lymph nodes.